Stem Cell Transplantation for Neurodegenerative Disease: A Distant Dream?

• Evans MJ , KaufmanMH. Establishment in culture of pluripotential cells from mouse embryos. Nature292(5819), 154–156(1981).
   PubMed Web of Science ®Google Scholar
• Amit M , CarpenterMK, InokumaMSet al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227(2), 271–278(2000).
   PubMed Web of Science ®Google Scholar
• Wilmut I , SchniekeAE, McWhirJ, KindAJ, CampbellKH. Viable offspring derived from fetal and adult mammalian cells. Nature385(6619), 810–813(1997).
   PubMed Web of Science ®Google Scholar
• Yu J , ThomsonJA. Pluripotent stem cell lines. Genes Dev.22(15), 1987–1997(2008).
   PubMed Web of Science ®Google Scholar
• Takahashi K , YamanakaS. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126(4), 663–676(2006).
   PubMed Web of Science ®Google Scholar
• Meissner A , WernigM, JaenischR. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol.25(10), 1177–1181(2007).
   PubMed Web of Science ®Google Scholar
• Okita K , IchisakaT, YamanakaS. Generation of germline-competent induced pluripotent stem cells. Nature448(7151), 313–317(2007).
   PubMed Web of Science ®Google Scholar
• Wernig M , MeissnerA, ForemanRet al. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature448(7151), 318–324(2007).
   PubMed Web of Science ®Google Scholar
• Wernig M , ZhaoJP, PruszakJet al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson‘s disease. Proc. Natl Acad. Sci. USA 105(15), 5856–5861(2008).
   PubMed Web of Science ®Google Scholar
• Yu J , VodyanikMA, Smuga-OttoKet al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858), 1917–1920(2007).
   PubMed Web of Science ®Google Scholar
• Pang ZP , YangN, VierbuchenTet al. Induction of human neuronal cells by defined transcription factors. Nature 476(7359), 220–223(2011).
   PubMed Web of Science ®Google Scholar
• Pfisterer U , KirkebyA, TorperOet al. Direct conversion of human fibroblasts to dopaminergic neurons. Proc. Natl Acad. Sci. USA 108(25), 10343–10348(2011).
   PubMed Web of Science ®Google Scholar
• Vierbuchen T , OstermeierA, PangZP, KokubuY, SudhofTC, WernigM. Direct conversion of fibroblasts to functional neurons by defined factors. Nature463(7284), 1035–1041(2010).
   PubMed Web of Science ®Google Scholar
• Han DW , TapiaN, HermannAet al. Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 10(4), 465–472(2012).
   PubMed Web of Science ®Google Scholar
• Lujan E , ChandaS, AhleniusH, SudhofTC, WernigM. Direct conversion of mouse fibroblasts to self-renewing, tripotent neural precursor cells. Proc. Natl Acad. Sci. USA109(7), 2527–2532(2012).
   PubMed Web of Science ®Google Scholar
• Thier M , WorsdorferP, LakesYBet al. Direct conversion of fibroblasts into stably expandable neural stem cells. Cell Stem Cell 10(4), 473–479(2012).
   PubMed Web of Science ®Google Scholar
• Kelly CM , DunnettSB, RosserAE. Medium spiny neurons for transplantation in Huntington‘s disease. Biochem. Soc. Trans.37(Pt 1), 323–328(2009).
   PubMed Web of Science ®Google Scholar
• Bowen JD , KraftGH, WundesAet al. Autologous hematopoietic cell transplantation following high-dose immunosuppressive therapy for advanced multiple sclerosis: long-term results. Bone Marrow Transplant. 47(7), 946–951(2012).
   PubMed Web of Science ®Google Scholar
• Meng L , OuyangJ, ZhangH, WenY, ChenJ, ZhouJ. Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation. Restor. Neurol. Neurosci.29(3), 177–185(2011).
   PubMed Web of Science ®Google Scholar
• Muraro PA , AbrahamssonSV. Resetting autoimmunity in the nervous system: the role of hematopoietic stem cell transplantation. Curr. Opin. Investig. Drugs11(11), 1265–1275(2010).
   PubMedGoogle Scholar
• Zuccato C , LiberD, RamosCet al. Progressive loss of BDNF in a mouse model of Huntington‘s disease and rescue by BDNF delivery. Pharmacol. Res. 52(2), 133–139(2005).
   PubMed Web of Science ®Google Scholar
• Olson SD , PollockK, KambalAet al. Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington‘s disease. Mol. Neurobiol. 45(1), 87–98(2012).
   PubMed Web of Science ®Google Scholar
• Tamaki SJ , JacobsY, DohseMet al. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis. Cell Stem Cell 5(3), 310–319(2009).
   PubMed Web of Science ®Google Scholar
• Mazzini L , FagioliF, BoccalettiRet al. Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 4(3), 158–161(2003).
   PubMed Web of Science ®Google Scholar
• Mazzini L , FerreroI, LuparelloVet al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a Phase I clinical trial. Exp. Neurol. 223(1), 229–237(2010).
   PubMed Web of Science ®Google Scholar
• Savitz SI , DinsmoreJH, WechslerLR, RosenbaumDM, CaplanLR. Cell therapy for stroke. NeuroRx1(4), 406–414(2004).
   PubMedGoogle Scholar
• Orive G , HernandezRM, MuruaA, PedrazJL. Recent advances in the use of encapsulated cells for effective delivery of therapeutics. Ther. Deliv.1(3), 387–396(2010).
   PubMedGoogle Scholar
• Zurn AD , HenryH, SchluepMet al. Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells. Cell. Transplantation 9(4), 471–484(2000).
   PubMed Web of Science ®Google Scholar
• Bloch J , Bachoud-LeviAC, DeglonNet al. Neuroprotective gene therapy for Huntington‘s Disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a Phase I study. Hum. Gene Ther. 15(10), 968–975(2004).
   PubMed Web of Science ®Google Scholar
• Klinge PM , HarmeningK, MillerMCet al. Encapsulated native and glucagon-like peptide-1 transfected human mesenchymal stem cells in a transgenic mouse model of Alzheimer‘s disease. Neurosci. Lett. 497(1), 6–10(2011).
   PubMed Web of Science ®Google Scholar
• Knippenberg S , ThauN, DenglerR, BrinkerT, PetriS. Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of ALS. PLoS One7(6), e36857 (2012).
   PubMed Web of Science ®Google Scholar
• Heile AM , WallrappC, KlingePMet al. Cerebral transplantation of encapsulated mesenchymal stem cells improves cellular pathology after experimental traumatic brain injury. Neurosci. Lett. 463(3), 176–181(2009).
   PubMed Web of Science ®Google Scholar
• Gupta N , HenryRG, StroberJet al. Neural stem cell engraftment and myelination in the human brain. Sci. Transl Med. 4(155), 155ra137 (2012).
   PubMed Web of Science ®Google Scholar
• Uchida N , ChenK, DohseMet al. Human neural stem cells induce functional myelination in mice with severe dysmyelination. Sci. Transl Med. 4(155), 155ra136 (2012).
   PubMed Web of Science ®Google Scholar
• Olanow CW , KollerW, GoetzCGet al. Autologous transplantation of adrenal medulla in Parkinson‘s disease. 18-month results. Arch. Neurol. 47(12), 1286–1289(1990).
   PubMedGoogle Scholar
• Watts RL , SubramanianT, FreemanAet al. Effect of stereotaxic intrastriatal cografts of autologous adrenal medulla and peripheral nerve in Parkinson‘s disease: two-year follow-up study. Exp. Neurol. 147(2), 510–517(1997).
   PubMed Web of Science ®Google Scholar
• Bye CR , ThompsonLH, ParishCL. Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice. Exp. Neurol.236(1), 58–68(2012).
   PubMed Web of Science ®Google Scholar
• Olanow CW , GoetzCG, KordowerJHet al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson‘s disease. Ann. Neurol. 54(3), 403–414(2003).
   PubMed Web of Science ®Google Scholar
• Freed CR , GreenePE, BreezeREet al. Transplantation of embryonic dopamine neurons for severe Parkinson‘s disease. N. Engl. J. Med. 344(10), 710–719(2001).
   PubMed Web of Science ®Google Scholar
• Kuan WL , ZhaoJW, BarkerRA. The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson‘s disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram. Psychopharmacology197(2), 279–293(2008).
   PubMed Web of Science ®Google Scholar
• Lee S -H, Lumelsky N, Studer L, Auerbach JM, Mckay R. Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol.18, 675–679(2000).
   PubMed Web of Science ®Google Scholar
• Bjorklund LM , Sânchez-PernauteR, ChungSet al. Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc. Natl Acad. Sci. USA 99(4), 2344–2349(2002).
   PubMed Web of Science ®Google Scholar
• Kawasaki H , MizusekiK, NishikawaSet al. Induction of midbrain dopaminergic neurons from ES cells by stromal cell-derived inducing activity. Neuron 28(1), 31–40(2000).
   PubMed Web of Science ®Google Scholar
• Kim JH , AuerbachJM, Rodriguez-GomezJAet al. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson‘s disease. Nature 418(6893), 50–56(2002).
   PubMed Web of Science ®Google Scholar
• Roy NS , ClerenC, SinghSK, YangL, BealMF, GoldmanSA. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med.12(11), 1259–1268(2006).
   PubMed Web of Science ®Google Scholar
• Ferri AL , LinW, MavromatakisYEet al. Foxa1 and Foxa2 regulate multiple phases of midbrain dopaminergic neuron development in a dosage-dependent manner. Development134(15), 2761–2769(2007).
   PubMed Web of Science ®Google Scholar
• Kittappa R , ChangWW, AwatramaniRB, McKayRD. The foxa2 gene controls the birth and spontaneous degeneration of dopamine neurons in old age. PLoS Biol.5(12), e325 (2007).
   PubMed Web of Science ®Google Scholar
• Nunes I , TovmasianLT, SilvaRM, BurkeRE, GoffSP. Pitx3 is required for development of substantia nigra dopaminergic neurons. Proc. Natl Acad. Sci. USA100(7), 4245–4250(2003).
   PubMed Web of Science ®Google Scholar
• Kriks S , ShimJW, PiaoJet al. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson‘s disease. Nature 480(7378), 547–551(2011).
   PubMed Web of Science ®Google Scholar
• Aubry L , BugiA, LefortN, RousseauF, PeschanskiM, PerrierAL. Striatal progenitors derived from human ES cells mature into DARPP32 neurons in vitro and in quinolinic acid-lesioned rats. Proc. Natl Acad. Sci. USA105(43), 16707–16712(2008).
   PubMed Web of Science ®Google Scholar
• El-Akabawy G , MedinaLM, JeffriesA, PriceJ, ModoM. Purmorphamine increases DARPP-32 differentiation in human striatal neural stem cells through the hedgehog pathway. Stem Cells Dev.20(11), 1873–1887(2011).
   PubMed Web of Science ®Google Scholar
• Ma L , HuB, LiuYet al. Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice. Cell Stem Cell 10(4), 455–464(2012).
   PubMed Web of Science ®Google Scholar
• Brederlau A , CorreiaAS, AnisimovSVet al. Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson‘s disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells 24(6), 1433–1440(2006).
   PubMed Web of Science ®Google Scholar
• Schuldiner M , Itskovitz-EldorJ, BenvenistyN. Selective ablation of human embryonic stem cells expressing a ‘suicide’ gene. Stem Cells21(3), 257–265(2003).
   PubMed Web of Science ®Google Scholar
• Choo AB , TanHL, AngSNet al. Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells 26(6), 1454–1463(2008).
   PubMed Web of Science ®Google Scholar
• Tan HL , FongWJ, LeeEH, YapM, ChooA. mAb 84, a cytotoxic antibody that kills undifferentiated human embryonic stem cells via oncosis. Stem Cells27(8), 1792–1801(2009).
   PubMed Web of Science ®Google Scholar
• Fong CY , PehGS, GauthamanK, BongsoA. Separation of SSEA-4 and TRA-1–60 labelled undifferentiated human embryonic stem cells from a heterogeneous cell population using magnetic-activated cell sorting (MACS) and fluorescence-activated cell sorting (FACS). Stem Cell Rev.5(1), 72–80(2009).
   PubMed Web of Science ®Google Scholar
• Blum B , Bar-NurO, Golan-LevT, BenvenistyN. The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat. Biotechnol.27(3), 281–287(2009).
   PubMed Web of Science ®Google Scholar
• Unger C , SkottmanH, BlombergP, DilberMS, HovattaO. Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum. Mol. Genet.17(R1), R48–R53 (2008).
   PubMed Web of Science ®Google Scholar
• Ellerstrom C , StrehlR, MoyaKet al. Derivation of a xeno-free human embryonic stem cell line. Stem Cells 24(10), 2170–2176(2006).
   PubMed Web of Science ®Google Scholar
• Belardelli F , RizzaP, MorettiF, CarellaC, GalliMC, MigliaccioG. Translational research on advanced therapies. Ann. Ist. Super. Sanita47(1), 72–78(2011).
   PubMed Web of Science ®Google Scholar
• Gage FH . Mammalian neural stem cells. Science287, 1433–1438(2000).
   PubMed Web of Science ®Google Scholar

Websites

• Study of HuCNS-SC Cells in Patients With Infantile or Late Infantile Neuronal Ceroid Lipofuscinosis (NCL). www.clinicaltrials.gov/ct2/show/NCT00337636
   Google Scholar
• Human Tissue Authority. Advanced therapy medicinal products FAQs. www.hta.gov.uk
   Google Scholar